Odysight.ai COO granted 40,000 stock options

Odysight.ai Inc. reported that Chief Operating Officer Tanami Ronen received a grant of 40,000 options to purchase common stock at an exercise price of $5.09 per share.

Rhea-AI Filing Summary

Odysight.ai Inc. reported that Chief Operating Officer Tanami Ronen received a grant of 40,000 options to purchase common stock at an exercise price of $5.09 per share. One-third of the options vest on May 19, 2027, with the rest vesting quarterly over the following 24 months, becoming fully vested on May 19, 2029. After this award, Ronen holds 40,000 options directly, which expire on May 19, 2036. This is a compensation-related grant, not an open-market share purchase or sale.

Insider Trade Summary

Grant/Award: 40,000 shares

Grant/Award 1 txn

Insider Tanami Ronen

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Options to purchase common stock (right to buy)	40,000	$0.00	$0.00

Holdings After Transaction: Options to purchase common stock (right to buy) — 40,000 contracts (Direct)

Footnotes (1)

1. F1. The stock option vests and becomes exercisable as to one-third of the total shares on May 19, 2027 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on May 19, 2029.

Key Figures

Options granted: 40,000 options Exercise price: $5.09 per share Total options after grant: 40,000 options +3 more

6 metrics

Options granted 40,000 options Grant of options to COO on May 19, 2026

Exercise price $5.09 per share Stock option strike price

Total options after grant 40,000 options Holdings following transaction

Initial vesting date May 19, 2027 One-third of options vest

Full vesting date May 19, 2029 All options vested and exercisable

Option expiration May 19, 2036 Last date to exercise options

Key Terms

stock option, vests and becomes exercisable, exercise price, Form 4

4 terms

stock option financial

"The stock option vests and becomes exercisable as to one-third of the total shares"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

vests and becomes exercisable financial

"The stock option vests and becomes exercisable as to one-third of the total shares on May 19, 2027"

exercise price financial

"conversion_or_exercise_price": "5.0900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Odysight.ai (ODYS) disclose about COO Tanami Ronen in this Form 4?

Odysight.ai disclosed that Chief Operating Officer Tanami Ronen received a grant of 40,000 stock options. These options are compensation, giving the right to buy common shares at a fixed price if specified vesting and time conditions are met.

How many stock options did the Odysight.ai (ODYS) COO receive and at what price?

The COO received 40,000 options to purchase Odysight.ai common stock at an exercise price of $5.09 per share. This fixed price applies if and when the options vest and are exercised before their expiration date in 2036.

What is the vesting schedule for the Odysight.ai (ODYS) COO’s 40,000 options?

One-third of the 40,000 options vest and become exercisable on May 19, 2027. The remaining options vest in equal quarterly installments over the following 24 months, so all 40,000 options are fully vested and exercisable by May 19, 2029.

When do the Odysight.ai (ODYS) COO’s stock options expire?

The 40,000 options granted to the COO expire on May 19, 2036. If they are not exercised by that date, the right to buy Odysight.ai common stock at the $5.09 exercise price lapses and the options become worthless.

Does this Odysight.ai (ODYS) Form 4 show any insider share sales or purchases?

No open-market share sales or purchases are reported. The Form 4 shows a grant of 40,000 stock options as compensation, coded as an acquisition (grant/award), rather than any purchase or sale of existing Odysight.ai common shares in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tanami Ronen

(Last) (First) (Middle)

C/O ODYSIGHT AI INC.

12 ABBA HILLEL SILVER RD

(Street)

RAMAT GAN ISRAEL 5250606

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Odysight.ai Inc. [ ODYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock (right to buy)	$5.09	05/19/2026		A		40,000		(1)	05/19/2036	Common Stock	40,000	$0	40,000	D

Explanation of Responses:

1. The stock option vests and becomes exercisable as to one-third of the total shares on May 19, 2027 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on May 19, 2029.

	/s/ Ronen Tanami	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)